HERON THERAPEUTICS, INC.

Company

HERON THERAPEUTICS, INC. /DE/

Filed

November 12, 2024

Accession Number

0000902664-24-006401

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →